These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28292926)

  • 1. MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and pregnancy: a contemporary review.
    Abucham J; Bronstein MD; Dias ML
    Eur J Endocrinol; 2017 Jul; 177(1):R1-R12. PubMed ID: 28292926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature.
    Cheng S; Grasso L; Martinez-Orozco JA; Al-Agha R; Pivonello R; Colao A; Ezzat S
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):264-71. PubMed ID: 21777265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in acromegaly: a one-center experience.
    Cozzi R; Attanasio R; Barausse M
    Eur J Endocrinol; 2006 Aug; 155(2):279-84. PubMed ID: 16868141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
    Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of acromegaly: a current perspective.
    Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
    Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional metabolic effects of adding GH receptor antagonist to long-acting somatostatin analog in patients with active acromegaly.
    Jawiarczyk A; Kałuzny M; Bolanowski M; Bednarek-Tupikowska G
    Neuro Endocrinol Lett; 2008 Aug; 29(4):571-6. PubMed ID: 18766168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy in women after successful acromegaly treatment, including surgical removal of pituitary adenoma and postoperative therapy using lanreotide acetate.
    Teltayev D; Akshulakov S; Ryskeldiev N; Mustafin K; Vyacheslav L
    Gynecol Endocrinol; 2017; 33(sup1):50-51. PubMed ID: 29264984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and acromegaly: a review.
    Cheng V; Faiman C; Kennedy L; Khoury F; Hatipoglu B; Weil R; Hamrahian A
    Pituitary; 2012 Mar; 15(1):59-63. PubMed ID: 21789529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acromegaly: new principles for treatment].
    Jørgensen JO; Feldt-Rasmussen UF; Andersen M; Kristensen LØ; Laurberg P; Weeke J
    Ugeskr Laeger; 2007 Mar; 169(10):904-6. PubMed ID: 17359733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic management of acromegaly].
    Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
    Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly and pregnancy.
    Caron P
    Ann Endocrinol (Paris); 2011 Sep; 72(4):282-286. PubMed ID: 21820101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the treatment of acromegaly].
    Krysiak R; Okopień B; Marek B
    Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of endocrine disease: GH excess: diagnosis and medical therapy.
    Andersen M
    Eur J Endocrinol; 2014 Jan; 170(1):R31-41. PubMed ID: 24144967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly: a new therapy.
    Friend KE
    Cancer Control; 2002; 9(3):232-5. PubMed ID: 12090246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.